EDITORIAL
| Issue | Title | |
| No 2 (2016) | COMMENT OF CHIEF EDITOR N.A. GRATSIANSKI | Abstract PDF (Rus) |
| No 1 (2016) | COMMENT EDITOR N.A.GRATSIANSKY | Abstract PDF (Rus) |
| N. A. | ||
| 1 - 2 of 2 Items | ||
Section Details
Popular articles
No 2 (2017)
No 1 (2020)
No 1 (2016)
Keywords
COVID-19
acetylsalicylic acid
acute coronary syndrome
anticoagulant therapy
aortic aneurysm
apixaban
atrial fibrillation
bleeding
clopidogrel
dabigatran
direct oral anticoagulants
myocardial infarction
percutaneous coronary intervention
prasugrel
rivaroxaban
thrombosis
warfarin
апиксабан
ацетилсалициловая кислота
ривароксабан
фибрилляция предсердий
105005, Tupolev PJSC, 15/2 Academician Tupolev Embankment, Moscow, Russia
“REMEDIUM GROUP” LRD
Phone. +7 (495) 780-34-25
